Nilotinib

Author： Plosker Greg L.   Robinson Dean M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.4, 2008-01, pp. : 449-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nilotinib: A Viewpoint by Gianantonio Rosti

By Rosti Gianantonio  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 460-461

Adis International

Access to resources Recommend Favorite

NICE recommends nilotinib and golimumab . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Dasatinib/imatinib/nilotinib: Cardiomyopathy (first report for nilotinib): case report

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Nilotinib launched for Ph+ CML in the UK.

By  

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The expanding role of nilotinib in chronic myeloid leukemia

By Kim Theo Daniel   Coutre Philipp le  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 97-107

Informa Healthcare

Access to resources Recommend Favorite